Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer

por Geissler, J, Sharf, G, Cugurovic, J, Padua, R, Narbutas, Š, Remic, M, Venkatesh, V
Publicado 2016

PB1902: ASC4OPT TRIAL IN PROGRESS: A PHASE 3B OPEN-LABEL OPTIMIZATION STUDY OF ORAL ASCIMINIB IN CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE PREVIOUSLY TREATED WITH 2 OR MORE TYR...

por Breccia, M., Turkina, A., Boquimpani, C., Chuah, C., Sharf, G., Schuld, P., Hoch, M., Yssel, J., Zhang, Y., Hochhaus, A.
Publicado 2022